Recent studies demonstrated that GATA3 suppressed breast cancer dissemination from the primary site by inhibiting epithelial-to-mesenchymal transition (EMT) and alterations of the tumor microenvironment, such as angiogenesis, collagen remodeling, and proteolysis 9-11. This evidence concerns the gene GATA3 and breast cancer.